Novakova IR - Search Results

1

Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.

Kluijtmans LA, Boers GH, Verbruggen B, Trijbels FJ, Novakova IR, Blom HJ. Kluijtmans LA, et al. Among authors: novakova ir. Blood. 1998 Mar 15;91(6):2015-8. Blood. 1998. PMID: 9490685 Free article.

2

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.

van der Molen EF, Verbruggen B, Nováková I, Eskes TK, Monnens LA, Blom HJ. van der Molen EF, et al. BJOG. 2000 Jun;107(6):785-91. doi: 10.1111/j.1471-0528.2000.tb13341.x. BJOG. 2000. PMID: 10847236 Clinical Trial.

3

Factor VIIA determination compared to D-Dimer in diagnosis of deep venous thrombosis.

Janssen MC, Verbruggen BW, ter Hark PJ, Nováková IR. Janssen MC, et al. Among authors: novakova ir. Thromb Res. 1997 Jun 1;86(5):423-6. doi: 10.1016/s0049-3848(97)00088-1. Thromb Res. 1997. PMID: 9211634 Free article. No abstract available.

4

Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: current status and new developments.

Janssen MC, Wollersheim H, Verbruggen B, Nováková IR. Janssen MC, et al. Among authors: novakova ir. Semin Thromb Hemost. 1998;24(4):393-400. doi: 10.1055/s-2007-996028. Semin Thromb Hemost. 1998. PMID: 9763357 Review.

5

Familial cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency type 1.

Franken DG, Vreugdenhil A, Boers GH, Verrips A, Blom HJ, Novakova IR. Franken DG, et al. Among authors: novakova ir. Stroke. 1993 Oct;24(10):1599-600. doi: 10.1161/01.str.24.10.1599. Stroke. 1993. PMID: 8378967

6

Diagnosis of factor VIII deficiency.

Verbruggen B, Meijer P, Novákova I, Van Heerde W. Verbruggen B, et al. Haemophilia. 2008 Jul;14 Suppl 3:76-82. doi: 10.1111/j.1365-2516.2008.01715.x. Haemophilia. 2008. PMID: 18510526 Review.

7

Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.

van de Locht LT, Kuypers AW, Verbruggen BW, Linssen PC, Nováková IR, Mensink EJ. van de Locht LT, et al. Among authors: novakova ir. Thromb Haemost. 1995 Nov;74(5):1276-9. Thromb Haemost. 1995. PMID: 8607109

8

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.

Boekhorst J, Verbruggen B, Lavergne JM, Costa JM, Schoormans SC, Brons PP, van Kraaij MG, Nováková IR, van Heerde WL. Boekhorst J, et al. Among authors: novakova ir. Br J Haematol. 2005 Oct;131(1):109-17. doi: 10.1111/j.1365-2141.2005.05737.x. Br J Haematol. 2005. PMID: 16173970 Free article.

9

The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.

Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. Verbruggen B, et al. Thromb Haemost. 1995 Feb;73(2):247-51. Thromb Haemost. 1995. PMID: 7792738

10

Meloxicam, 15 mg/day, spares platelet function in healthy volunteers.

de Meijer A, Vollaard H, de Metz M, Verbruggen B, Thomas C, Novakova I. de Meijer A, et al. Clin Pharmacol Ther. 1999 Oct;66(4):425-30. doi: 10.1053/cp.1999.v66.a101063. Clin Pharmacol Ther. 1999. PMID: 10546927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters